review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Vineet Ahuja | |
Saurabh Kedia | |||
Rakesh Tandon | |||
P2860 | cites work | Outcome following emergency surgery for refractory severe ulcerative colitis in a tertiary care centre in India | Q25256972 |
Risk factors for inflammatory bowel disease in the general population | Q28186843 | ||
Cyclosporine in severe ulcerative colitis refractory to steroid therapy | Q34060783 | ||
Small bowel gas in severe ulcerative colitis | Q34395164 | ||
Predicting outcome in severe ulcerative colitis | Q34409849 | ||
THE COURSE AND PROGNOSIS OF ULCERATIVE COLITIS. | Q34478028 | ||
Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up | Q34506976 | ||
Controlled trial of bowel rest in the treatment of severe acute colitis | Q34529542 | ||
Cytomegalovirus colitis complicating inflammatory bowel disease | Q34572006 | ||
Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases | Q34710712 | ||
A new look at toxic megacolon: an update and review of incidence, etiology, pathogenesis, and management | Q35593024 | ||
A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis | Q35768942 | ||
Mortality in patients with and without colectomy admitted to hospital for ulcerative colitis and Crohn's disease: record linkage studies | Q36145711 | ||
Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression | Q36671830 | ||
A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis | Q36720362 | ||
Adverse events associated with the use of cyclosporine in patients with inflammatory bowel disease | Q37051414 | ||
Clostridium difficile and inflammatory bowel disease | Q37165470 | ||
Surgery in ulcerative colitis: indication and timing | Q37604764 | ||
Increased health burden associated with Clostridium difficile diarrhoea in patients with inflammatory bowel disease | Q37868657 | ||
Incidence of colectomy during long-term follow-up after cyclosporine-induced remission of severe ulcerative colitis | Q40323292 | ||
Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology | Q40390478 | ||
Intravenous cyclosporin in ulcerative colitis: a five-year experience | Q41671378 | ||
Assessment of severity in colitis: a preliminary study | Q41988487 | ||
Infliximab in severe steroid-refractory ulcerative colitis: a pilot study. | Q42668130 | ||
Delayed surgery for acute severe colitis is associated with increased risk of postoperative complications | Q43184169 | ||
Gynaecological and sexual function related to anatomical changes in the female pelvis after restorative proctocolectomy. | Q43327810 | ||
Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis | Q43582796 | ||
Outcome of cytomegalovirus infections in patients with inflammatory bowel disease | Q43684194 | ||
A prospective randomized controlled trial of intravenous ciprofloxacin as an adjunct to corticosteroids in acute, severe ulcerative colitis | Q43719249 | ||
Long-term outcome after admission for acute severe ulcerative colitis in Oxford: the 1992-1993 cohort | Q44071902 | ||
Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study | Q44355973 | ||
Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease | Q44446912 | ||
Long-term results of low-dose intravenous ciclosporin for acute severe ulcerative colitis | Q44535154 | ||
Meta-analysis: effect of preoperative infliximab use on early postoperative complications in patients with ulcerative colitis undergoing abdominal surgery | Q44607322 | ||
Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab | Q44742543 | ||
Ciclosporin use in acute ulcerative colitis: a long-term experience | Q45221934 | ||
Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid-refractory ulcerative colitis: a retrospective observational study. | Q46130626 | ||
Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis | Q46152475 | ||
Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. | Q46531976 | ||
Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis | Q46990369 | ||
Cortisone in ulcerative colitis; preliminary report on a therapeutic trial | Q50417466 | ||
Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial. | Q53122367 | ||
Perioperative treatment with infliximab in patients with Crohn's disease and ulcerative colitis is not associated with an increased rate of postoperative complications. | Q53741447 | ||
Early predictors of glucocorticosteroid treatment failure in severe and moderately severe attacks of ulcerative colitis. | Q54115144 | ||
Intensive intravenous regimen for severe attacks of ulcerative colitis. | Q54394687 | ||
Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second-line medical therapy or surgery. | Q54563945 | ||
Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients. | Q54568296 | ||
Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis1 1Gert Van Assche, Severine Vermeire, Geert D’Haens, and Paul Rutgeerts have been instrumental in the design of the study, trial man | Q57265461 | ||
Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial | Q59120396 | ||
Impact of Hospital Volume on Postoperative Morbidity and Mortality Following a Colectomy for Ulcerative Colitis | Q59563688 | ||
Enteral versus parenteral nutrition as adjunct therapy in acute ulcerative colitis | Q70539279 | ||
Use of air enema radiography to assess depth of ulceration during acute attacks of ulcerative colitis | Q71133025 | ||
Colonoscopy of acute colitis. A safe and reliable tool for assessment of severity | Q72048490 | ||
Intravenous tobramycin and metronidazole as an adjunct to corticosteroids in acute, severe ulcerative colitis | Q72688420 | ||
Subtotal colectomy for severe acute colitis: a 20-year experience of a tertiary care center with an aggressive and early surgical policy | Q73880953 | ||
Management of acute severe colitis | Q79922499 | ||
Female infertility after ileal pouch-anal anastomosis for ulcerative colitis | Q80136298 | ||
Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis | Q80269736 | ||
Severe acute colitis associated with CMV: a prevalence study | Q81261144 | ||
Urgent subtotal colectomy for severe inflammatory bowel disease | Q81360173 | ||
Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy | Q81416000 | ||
Simple score to identify colectomy risk in ulcerative colitis hospitalizations | Q82599194 | ||
ULCERATIVE COLITIS: A SURVEY OF NINETY-FIVE CASES | Q84929815 | ||
P433 | issue | 4 | |
P304 | page(s) | 579-588 | |
P577 | publication date | 2014-11-01 | |
P1433 | published in | World journal of gastrointestinal pathophysiology | Q27723538 |
P1476 | title | Management of acute severe ulcerative colitis. | |
P478 | volume | 5 |
Q52346955 | Chinese research into severe ulcerative colitis has increased in quantity and complexity. |
Q34454060 | Evaluation of dairy allergy among ulcerative colitis patients. |
Q88619085 | Healthy hosts rule within: ecological forces shaping the gut microbiota |
Q47652740 | Observational Study of Perspectives of Inflammatory Bowel Disease Patients Concerning the Use of Corticosteroids |
Q89047085 | Salvage therapy for acute severe ulcerative colitis during pregnancy |
Q88677985 | Sarcopenia is a Novel Predictor of the Need for Rescue Therapy in Hospitalized Ulcerative Colitis Patients |
Q38575522 | Surgical and medical treatment in patients with acute severe ulcerative colitis |
Q61821109 | Systematic Review and Meta-analysis: Optimal Salvage Therapy in Acute Severe Ulcerative Colitis |
Q28073443 | Update on medical and surgical options for patients with acute severe ulcerative colitis: What is new? |
Search more.